CSIMarket Company Name, Ticker, Customers, else..
 
Aardvark Therapeutics Inc   (NASDAQ: AARD)
 
Price: $5.2700 $0.21 4.150%
Day's High: $5.320000171661377 Week Perf: -8.35 %
Day's Low: $ 4.96 30 Day Perf: -20.39 %
Volume (M): 60,648 52 Wk High: $ 17.94
Volume (M$): $ 0 52 Wk Avg: $8.48
Open: $5.05 52 Wk Low: $3.35



 Market Capitalization (Millions $) 115
 Shares Outstanding (Millions) 22
 Employees 40
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -70
 Cash Flow (TTM) (Millions $) 36
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company conducts research, development, and clinical testing of product candidates aimed at treating specific diseases and conditions. Its activities include advancing preclinical studies and clinical trials, securing regulatory approvals, manufacturing, and commercializing product candidates, as well as managing strategic collaborations and financial resources.


   Company Address: 4370 La Jolla Village Drive San Diego 92122 CA
   Company Phone Number: 225-7696   Stock Exchange / Ticker: NASDAQ AARD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Aardvark Therapeutics Pioneering Innovations in Obesity Management with ARD-201

Published Tue, Nov 4 2025 9:37 PM UTC

In the ever-evolving landscape of obesity treatment, Aardvark Therapeutics has emerged as a beacon of innovation. Recent presentations at ObesityWeek 2025 underscored the company’s commitment to addressing one of the most pressing health issues of our time. Central to their focus is a promising candidate drug, ARD-201, which recently showcased exciting preclinical results ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 1.54
PEG (TTM) -

Financial Strength Current
Quick Ratio 11.57
Working Capital Ratio 12.82
Leverage Ratio (MRQ) 0.09
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -3.3 $
Revenues (TTM) -
Cash Flow (TTM) 1.67 $
Cash 3.38 $
Book Value 3.42 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,747,225
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.